Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Total Liabilities: 2020-2022

Historic Total Liabilities for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $26.1 million.

  • Cullinan Therapeutics' Total Liabilities fell 16.78% to $25.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $25.9 million, marking a year-over-year decrease of 16.78%. This contributed to the annual value of $26.1 million for FY2022, which is 120.88% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Total Liabilities stood at $26.1 million for FY2022, which was up 120.88% from $11.8 million recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Total Liabilities registered a high of $26.1 million during FY2022, and its lowest value of $11.8 million during FY2021.
  • In the last 3 years, Cullinan Therapeutics' Total Liabilities had a median value of $14.4 million in 2020 and averaged $17.4 million.
  • As far as peak fluctuations go, Cullinan Therapeutics' Total Liabilities decreased by 17.94% in 2021, and later spiked by 120.88% in 2022.
  • Over the past 3 years, Cullinan Therapeutics' Total Liabilities (Yearly) stood at $14.4 million in 2020, then dropped by 17.94% to $11.8 million in 2021, then skyrocketed by 120.88% to $26.1 million in 2022.